Introduction
Helicobacter species are Gram-negative, spiral-shaped bacteria. Helicobacter species other than H. pylori, including H. heilmannii and H. felis, also referred to as H. heilmannii-like organisms (HHLOs), have been identified in gastric mucosa-associated lymphoid tissue lymphoma and peptic ulcer in humans. HHLOs are found in a small percentage of human subjects (0.1-6%) [1, 2] ; however, HHLO infection is prevalent in gastric mucosa-associated lymphoid tissue lymphoma [3, 4] . HHLO infection is very common in dogs, cats, pigs and nonhuman primates [5, 6] .
HHLO infection is most frequently diagnosed by histopathology to identify the organism's morphology. Culture of HHLOs by traditional H. pylori culture techniques is difficult, although one research group has been successful [7] . The 13 C urea breath test (UBT) may be used to detect gastric HHLOs in animals [5, 8] . Some human cases have yielded positive results by the rapid urease test (RUT), the UBT and anti-H. pylori antibody, although the sensitivity of these tests is unclear. We report a case of nodular gastritis with HHLO infection diagnosed as H. suis by genetic sequencing. We also review the sensitivity of HHLO diagnostic methods.
Methods

DNA Extraction
Gastric biopsy samples were digested in SNET buffer (1% SDS, 400 mM NaCl, 5 mM EDTA, 20 mM Tris-HCl, pH 8.0) containing proteinase K (0.2 mg/ml) overnight at 50°C. After 10-min incubation at 95°C, the sample was serially diluted tenfold. The DNA was stored at -20°C until use.
Amplification of HHLO-Specific or H. pylori-Specific DNA
At least 1-, 10-or 100-fold diluted samples were used as DNA templates for polymerase chain reaction (PCR). PCR amplification involved Ampdirect ® Plus (Shimadzu Corporation, Kyoto, Japan), BIOTAQ TM HS DNA Polymerase (Shimadzu Corporation), 0.5 µM each of primers HeilF and HeilR (HHLO-specific) or VAC3624F and VAC4041R (H. pylori-specific) [9] using a CFX96 thermal cycler (Bio-Rad Laboratories Inc., Hercules, Calif., USA).
Amplification and Sequencing of Urease Genes
Urease genes were amplified using primer pairs U430F and U1735R or U430F and U2235R (urease two, 1,752 bp) [10] . The products were sequenced commercially (Fasmac Co. Ltd., Atsugi, Japan) with the same primers and other primers (U850F, U1050R and U1350F) [10] . The sequences were compared with those in the NCBI GenBank by using the BLAST search tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Case Presentation
In June 2013, a 48-year-old woman was diagnosed with nodular gastritis by esophagogastroduodenal endoscopy at Marin clinic. Histology was positive for HHLO. Nothing abnormal except for gastritis was pointed out. The patient was referred to Aichi Medical University Hospital for treatment in August. She did not have any related medical history and had never come in contact with domestic animals, including cats and dogs. Esophagogastroduodenal endoscopy showed antral nodular gastritis without mucosal atrophy; the corpus was normal ( fig. 1 ). The 13 C UBT finding was positive with a 13 C value of 3.3% (cutoff value 2.5%). The RUT (PYLORITEK ® , Serim Research Corp., Elkhart, Ind., USA) finding was positive in 30 min, but the results of the stool antigen and serum anti-H. pylori IgG antibody tests were negative. However, HHLO of characteristic morphology was found in the antral mucosa and in a gastric pit only ( fig. 2) . Histopathology showed mild chronic gastritis in the stomach antrum and corpus mucosa and no atrophy or intestinal metaplasia. The patient was treated with a 7-day course of triple therapy consisting of esomeprazole, amoxicillin and clarithromycin. There were no adverse events. Two months after therapy, UBT findings were negative (0.8%).
We obtained informed consent from patients and investigated the HHLO by PCR. An HHLO-specific amplicon was obtained from the sample. The sequences of the 16S rRNA gene (1,167 bp; fig. 3a ) and the urease gene (916 bp, including a 4-bp undetermined sequence; fig. 3b ) were determined. The 16S rRNA gene sequence of the sample showed 99% (1,162/ 1,167) and 96% (1,117/1,165) sequence identity with that of H. suis type strain HS1 T (NR_044169) and H. heilmannii type strain ASB1 T (HE984298), respectively. The urease gene sequence of the sample showed 96% (882/918) sequence identity with sequences from GenBank accession no. AB968248, AB968247 and AF508001 from H. suis SH8, SH10 and HU4, respectively. The urease gene had 95% (772/815) identity with the sequence of H. suis type strain HS1 T (EF204592), whereas it had only 82% (659/801), 81% (727/894) and 80% (692/860) identity with corresponding sequences of H. bizzozeronii type strain Storkis T (AF508003), Candidatus H. heilmannii reference strain HU2 R (AF508012) and H. heilmannii type strain ASB1 T (HE984298), respectively. On the basis of both sequences, we conclude that the species of the strain is H. suis.
Discussion
We reported an asymptomatic patient with H. suis-infected nodular gastritis demonstrated by biopsy specimens. Genetic diagnosis of this infection by PCR was very useful to identify the HHLO species as H. suis.
HHLO is a zoonotic agent transmitted from animals to humans [11] , and most infected persons complain of dyspepsia, epigastric pain or acid reflux [12, 13] . However, the current patient had no contact with domestic animals, including cats and dogs. Moreover, she had no symptoms despite histologically mild chronic gastritis. Stolte and colleagues [3, 4, 14] reported that HHLO infection is more often focal, with fewer organisms, and usually restricted to the gastric antrum, with less severe gastritis than H. pylori infection, leading to the rarity of concurrent erosions and ulcers.
Gastric non-H. pylori helicobacters, which are morphologically long, spiral-shaped bacteria, were originally referred to as Gastrospirillum hominis and later as H. heilmannii [15] . The cells of this new species are tightly coiled spirals with up to six turns, which are approximately 2.3-6.7 µm long and 0.9-1.2 µm wide. They have bipolar tufts of 4-10 sheathed flagella that are blunt-ended or end in spherical knobs [15] .
The characteristic morphology of HHLOs can be identified in biopsy specimens stained with hematoxylin and eosin, Giemsa or Warthin-Starry silver stains. The present case was also diagnosed by morphology on the basis of gastric biopsy examination, as in many report-ed cases. However, HHLOs are better diagnosed on smears (touch cytology) than biopsies [13, 16] because they are typically found in the mucus layer above the surface and foveolar epithelial cells and do not show the intimate adherence, pedestal formation or invasion in the intercellular spaces often seen with H. pylori.
Other diagnostic tests in the present case showed positive results for UBT and RUT and negative results for stool antigen and serum anti-H. pylori IgG antibody. The sensitivity of diagnostic tests for HHLOs is summarized in table 1. The findings were as follows: RUT 40.0%, UBT 14.8%, culture 0%, blood antibody 23.1%, immunohistochemistry 40.0% and stool antigen 0%. As expected, in vitro culture of HHLO failed in 55 patients, although culture was successful in the cat stomach [17] . The urease test seems useful for diagnosing HHLO infection, although it is difficult to distinguish HHLO from H. pylori infection. The rate of urease positivity appears to be lower than that for H. pylori. HHLOs probably have a lower amount of urease than H. pylori, and the test might be positive only when numerous organisms are present in the tested specimen. The UBT and RUT tests are highly sensitive and specific for HHLO in animals, and the discrepancy in these diagnostic tests in humans and animals is unclear [5, 7] . Serological and immunohistochemical tests with H. pylori antibody yielded lower positivity rates for HHLO than for H. pylori infection itself. The enzyme-linked immunosorbent assay of stool with H. pylori polyclonal antigens showed cross-reactivity with HHLO antigens. It is critical to develop HHLO-specific antibodies for serological, immunohistochemical and stool tests.
In the present case, PCR was used to identify the species of HHLO as H. suis. PCR-based studies have been used to identify HHLOs in humans [4] and animals [3, 4, 18] . Chisholm and Owen [9] performed PCR using gastric biopsies, showing an HHLO prevalence rate of 2.3% in Southeast England. However, this prevalence rate is not as high as that diagnosed by morphology. PCR sensitivity for HHLOs may be lower in clinical practice, and the typical morphological features on hematoxylin and eosin staining seem sufficient to diagnose HHLO infection with chronic gastritis.
Conclusion
We describe asymptomatic nodular gastritis infection associated with an HHLO. Histological techniques, most likely with smears, will be the most effective method for diagnosing HHLO infection. Furthermore, genetic diagnosis by PCR was shown to be very useful to identify the species of non-H. pylori helicobacters.
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